In any case, our present study combined with others indicates that elevated levels of glucocorticoids found in sporadic AD brains [62-64] may not only be a consequence of the pathology but also play a causal role in triggering β-amyloidogenesis through BACE1 and APP elevations during earlier stages of disease progression. Here, APP is linked to Alzheimer disease.